|
|
Article: ALK-Abello: New Tablet-Based Immunotherapy for Grass Allergy Approved.
- Article from:
- PR Newswire Europe
- Article date:
- March 16, 2006
|
Copyright informationCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEyRSHOLM, Denmark, March 16 /PRNewswire/ --
- The Swedish Medical Products Agency has Approved ALK-Abello's Tablet-Based Immunotherapy, GRAZAX(R), for the Treatment of Grass Pollen Allergy. ALK-Abello will now Submit Applications for GRAZAX(R) in Other European Countries Using the Mutual Recognition Procedure
ALK-Abello's tablet-based immunotherapy, GRAZAX(R), has been approved by the Swedish Medical Products Agency for the treatment of grass pollen allergy.
ALK-Abello will now submit further applications in other European countries via the Mutual Recognition Procedure. ALK-Abello still expects GRAZAX(R) to be launched in the first European markets by the end ...
Related newspaper, magazine, and journal articles:
|
|
Article: Strong results for ALK-Abello's Grazax.(allergy vaccinations)(Brief Article)
Pharma Marketletter;
November 14, 2005 ;
124 words
......allergy vaccinations in Europe, says that clinical data on Grazax, its oral immunotherapy for grass pollen allergies, show that it reduces the symptoms of hay fever...quality of life. According to the firm, the data confirms that Grazax is an effective, safe and convenient treatment. They will...
|
|